← SynDRA
AP18 5
SynDRA canonical compound SYN0020346 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TRPA1 |
|---|
| Mechanism of action | transient receptor potential channel antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- transient receptor potential channel antagonist
Cross-references
Synonyms
- AP18
- MHTJEUOFLVQMCL-NJHPPEEMSA-N
- AP-18
- 4-(4-CHLOROPHENYL)-3-METHYL-3-BUTEN-2-ONE OXIME
- SCHEMBL12552586
- HMS557G21
- MolPort-002-910-651
- CCG-44686
- AKOS024457534
- AP-18, >
- SCHEMBL29357634
- NRB 01489
- CS-W015137
- HY-W014421
- Ap-18
- RefChem:558382
- 4-(4-CHLOROPHENYL)-3-METHYLBUT-3-EN-2-OXIME
- (2E,3E)-4-(4-chlorophenyl)-3-methylbut-3-en-2-one oxime
- 4-(4-Chlorophenyl)-3-methylbut-3-en-2-one oxime
- GTPL4134
- orb1306305
- FCA22494
- HB1157
- MFCD00102250
- AKOS040744873
- AP-18, >=98% (HPLC), solid
- DA-70978
- MS-23153
- T21543
- SR-01000634505-1
- (E)-4-(4-chlorophenyl)-3-methyl-but-3-en-2-one oxime
Look up AP18 5 in the interactive SynDRA portal →